BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 36428565)

  • 1. Use of dose-volume histograms for metabolic response prediction in hepatocellular carcinoma patients undergoing transarterial radioembolization with Y-90 resin microspheres.
    Coskun N; Kartal MO; Kartal AS; Cayhan V; Ozdemir M; Canyigit M; Ozdemir E
    Ann Nucl Med; 2024 Apr; ():. PubMed ID: 38647875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histopathologic Changes after Yttrium-90 Radioembolization of Colorectal Liver Metastases: A Pilot Feasibility Study.
    Kitsel Y; Vakiani E; Kirov A; Zirakchian Zadeh M; Kunin H; Petre EN; Crane CH; Romesser P; Sotirchos VS; Sofocleous CT
    J Vasc Interv Radiol; 2024 Apr; ():. PubMed ID: 38670528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FDG PET/CT Imaging of Sarcomatoid Hepatocellular Carcinomaļ¼šA case report.
    Chen Z; Wang H; Yu X
    Asian J Surg; 2024 Apr; ():. PubMed ID: 38664188
    [No Abstract]   [Full Text] [Related]  

  • 4. The Influence of Additional Treatments on the Survival of Patients Undergoing Transarterial Radioembolization (TARE).
    Quartuccio N; Ialuna S; Scalisi D; D'Amato F; Barcellona MR; Bavetta MG; Fusco G; Bronte E; Musso E; Bronte F; Picciotto V; Carroccio A; Verderame F; Malizia G; Cistaro A; La Gattuta F; Moreci AM
    Curr Oncol; 2024 Mar; 31(3):1504-1514. PubMed ID: 38534947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bench to Bedside Development of [
    Challapalli A; Barwick TD; Dubash SR; Inglese M; Grech-Sollars M; Kozlowski K; Tam H; Patel NH; Winkler M; Flohr P; Saleem A; Bahl A; Falconer A; De Bono JS; Aboagye EO; Mangar S
    Molecules; 2023 Dec; 28(24):. PubMed ID: 38138508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on PET Radiopharmaceuticals for Imaging Hepatocellular Carcinoma.
    Nyakale N; Filippi L; Aldous C; Sathekge M
    Cancers (Basel); 2023 Mar; 15(7):. PubMed ID: 37046636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The application of
    Yao Y; Civelek AC; Li XF
    Quant Imaging Med Surg; 2023 Sep; 13(9):6268-6279. PubMed ID: 37711813
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Hemrom A; Tupalli A; Alavi A; Kumar R
    PET Clin; 2022 Jul; 17(3):415-430. PubMed ID: 35717100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PET/CT with
    Filippi L; Bagni O; Notarianni E; Saltarelli A; Ambrogi C; Schillaci O
    Biomedicines; 2022 Nov; 10(11):. PubMed ID: 36428565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of Early Posttreatment PET/CT Evaluation Using FDG or
    Reizine E; Chalaye J; Mule S; Regnault H; Perrin C; Calderaro J; Laurent A; Amaddeo G; Kobeiter H; Tacher V; Itti E; Luciani A
    AJR Am J Roentgenol; 2022 Feb; 218(2):359-369. PubMed ID: 34494448
    [No Abstract]   [Full Text] [Related]  

  • 11. Total Lesion Glycolysis on 18F-FDG PET/CT Is a Better Prognostic Factor Than Tumor Dose on 90Y PET/CT in Patients With Hepatocellular Carcinoma Treated With 90Y Transarterial Radioembolization.
    Hwang SH; Hong HS; Kim D; Kim GM; Lee HW; Lee M; Kim DY; Park MA; Yun M
    Clin Nucl Med; 2022 Jun; 47(6):e437-e443. PubMed ID: 35384891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pilot comparison of 18F-fluorodeoxyglucose and 18F-fluorocholine PET/CT to predict early recurrence of unifocal hepatocellular carcinoma after surgical resection.
    Fartoux L; Balogova S; Nataf V; Kerrou K; Huchet V; Rosmorduc O; Talbot JN
    Nucl Med Commun; 2012 Jul; 33(7):757-65. PubMed ID: 22504293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PET/CT in patients with hepatocellular carcinoma using [(18)F]fluorocholine: preliminary comparison with [(18)F]FDG PET/CT.
    Talbot JN; Gutman F; Fartoux L; Grange JD; Ganne N; Kerrou K; Grahek D; Montravers F; Poupon R; Rosmorduc O
    Eur J Nucl Med Mol Imaging; 2006 Nov; 33(11):1285-9. PubMed ID: 16802155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of
    Piccardo A; Trimboli P; Puntoni M; Foppiani L; Treglia G; Naseri M; Bottoni GL; Massollo M; Sola S; Ferrarazzo G; Bruzzone M; Catrambone U; Arlandini A; Paone G; Ceriani L; Cabria M; Giovanella L
    Thyroid; 2019 Apr; 29(4):549-556. PubMed ID: 30864903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trans-arterial Radioembolization Dosimetry in 2022.
    Garin E; Guiu B; Edeline J; Rolland Y; Palard X
    Cardiovasc Intervent Radiol; 2022 Nov; 45(11):1608-1621. PubMed ID: 35982334
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.